Tracey Dawson is the founder of Rectify Pharmaceuticals. Rectify Pharmaceuticals has raised $100M in total funding. Latest round: Series A.
Tracey Dawson is the Chief Operating Officer of Rectify Pharmaceuticals. The company is developing disease-modifying therapeutics called Positive Functional Modulators (PFMs) to restore ABC transporter function for patients with serious genetic diseases. Rectify Pharmaceuticals launched with a $100 million Series A financing.
Full founder directory · Investor directory · Company funding database · Fundraising library